封面
市場調查報告書
商品編碼
1674112

生物可吸收植入市場按材料類型、應用、最終用戶和地區分類

Bioresorbable Implants Market, By Material Type, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 169 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年全球生物可吸收植入市場規模預計為 66.3 億美元,預計到 2032 年將達到 119 億美元,2025 年至 2032 年的複合年成長率為 8.7%。

報告範圍 報告詳細資訊
基準年 2024 2025 年市場規模 66.3億美元
效能資料 2020-2024 預測期 2025-2032
預測期:2025 年至 2032 年複合年成長率 8.70% 2032 年金額預測 119億美元
數字。 2025 年生物可吸收植入市場佔有率(按地區)
生物可吸收植入物市場-IMG1

生物可吸收植入是設計用於暫時留在體內並在達到預期目的後進行生物分解的醫療設備。生物可吸收植入由聚乳酸(PLLA)或Polyglycolic(PGA)等聚合物製成,會隨著時間的推移分解並被人體吸收。這減少了透過侵入性手術移除植入的需要。生物可吸收植入比傳統永久性植入具有顯著的優勢,包括更少的應力遮蔽、逐漸吸收、負荷轉移到癒合骨骼以及避免長期併發症。全球生物可吸收植入市場的成長得益於心臟和整形外科疾病盛行率的不斷上升、外科手術數量的不斷增加、生物可吸收材料相對於永久性植入的優勢以及技術進步。

市場動態

全球生物可吸收植入市場發展的關鍵驅動力是老年人口的增加,老年人更容易罹患心臟疾病和整形外科疾病。根據世界衛生組織估計,到2050年,65歲及以上人口預計將從2010年的5.24億增加到近15億。生物可吸收植入可降低永久性植入相關感染疾病的風險,且無需移除植入。這使得它們比傳統植入更受歡迎。此外,開發具有客製化分解率以適應每個組織癒合過程的先進可吸收聚合物正在推動市場成長。然而,與金屬植入相比,生物可吸收植入的成本更高,且低收入國家對此的認知度較低,這可能會阻礙市場的成長。正在進行的用於軟組織修復和藥物輸送的可吸收植入的研究和開發可以為製造商提供有利可圖的機會。

本研究的主要特點

  • 本研究報告對全球生物可吸收植入市場進行了詳細分析,並提供了預測期(2025-2032)的市場規模(十億美元)和年複合成長率(CAGR%),假設 2024 年為基準年。
  • 它強調了各個領域的潛在商機並解釋了該市場的有吸引力的投資提案矩陣。
  • 它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
  • 全球生物可吸收植入市場的主要企業是根據公司亮點、產品系列、關鍵亮點、性能和策略等參數進行的分析。
  • 本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 全球生物可吸收植入市場報告針對該行業的各個相關人員,例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
  • 相關人員將透過全球生物可吸收植入市場分析中使用的各種策略矩陣更輕鬆地做出決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • 一致的機會圖 (COM)

第3章市場動態、法規與趨勢分析

  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
  • 影響分析
  • 市場趨勢
  • 監管情景
  • 收購和合作場景
  • 資金籌措和投資
  • PEST分析
  • 波特的分析

4. 全球生物可吸收植入市場 - 冠狀病毒 (COVID-19) 疫情的影響

  • 整體影響
  • 政府舉措
  • COVID-19 市場影響

5. 全球生物可吸收植入市場(以材料類型),2020-2032 年(十億美元)

  • 介紹
  • 金屬
  • 聚合物

6. 2020-2032 年全球生物可吸收植入市場(按應用分類)(十億美元)

  • 介紹
  • 整形外科
  • 心血管
  • 其他

7. 2020-2032 年全球生物可吸收植入市場(按最終用戶分類)(十億美元)

  • 介紹
  • 醫院
  • 專科門診
  • 門診手術中心
  • 其他

8. 全球生物可吸收植入市場,按地區,2020-2032 年(十億美元)

  • 介紹
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第9章 競爭格局

  • 公司簡介
    • Abbott Laboratories
    • Medtronic plc
    • Johnson & Johnson
    • Stryker Corporation
    • Zimmer Biomet Holdings, Inc.
    • Smith & Nephew plc
    • Boston Scientific Corporation
    • BIoTronik SE & Co. KG
    • Terumo Corporation
    • Amaranth Medical, Inc.
    • Arthrex, Inc.
    • Bioretec Ltd.
    • REVA Medical, LLC
    • Tepha, Inc.
    • Corbion NV
    • DSM Biomedical
    • WL Gore & Associates, Inc.

第 10 章分析師建議

  • 興衰
  • 一致的機會地圖

第 11 章 參考文獻與調查方法

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI2478

Global Bioresorbable Implants Market is estimated to be valued at USD 6.63 Bn in 2025 and is expected to reach USD 11.90 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.7% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 6.63 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 8.70% 2032 Value Projection: USD 11.90 Bn
Figure. Bioresorbable Implants Market Share (%), By Region 2025
Bioresorbable Implants Market - IMG1

Bioresorbable implants are medical devices that are designed to remain in the body temporarily and undergo biodegradation after serving their intended purpose. Made from polymers such as polylactic acid (PLLA) and polyglycolic acid (PGA), bioresorbable implants degrade over time and are absorbed by the body. This alleviates the need for subsequent invasive surgery to remove implants. These offer significant benefits over traditional permanent implants by causing less stress shielding, resorbing gradually to transfer load to healing bone, and avoiding long-term complications. Global bioresorbable implants market growth is driven by growing prevalence of cardiac and orthopedic diseases, rising number of surgeries, advantages of bioresorbable materials over permanent implants, and technological advancements.

MARKET DYNAMICS:

Global bioresorbable implants market growth is primarily driven by rising geriatric population who are more prone to develop cardiac diseases and orthopedic disorders. As per WHO, the number of people aged 65 years and above is expected to increase from 524 million in 2010 to nearly 1.5 billion in 2050. Bioresorbable implants reduce the risk of permanent implant-related infections and eliminate the need for implant removal. This boosts their demand over conventional implants. Moreover, advanced resorbable polymers with customized degradation rate are being developed to suit individual tissue healing process, thus, driving the market growth. However, high costs of bioresorbable implants as compared to metal implants and lack of awareness in low-income nations can hamper the market growth. Ongoing R&D to develop resorbable implants for soft tissue repair and drug delivery can offer lucrative opportunities for manufacturers.

Key Features of the Study:

  • This report provides in-depth analysis of the global bioresorbable implants market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global bioresorbable implants market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include DePuy Synthes, Stryker, Smith & Nephew, Zimmer Biomet, Medtronic and Bioretec
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global bioresorbable implants market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bioresorbable implants market

Detailed Segmentation-

  • By Material Type
    • Metallic
    • Polymer
  • By Application
    • Orthopedic
    • Cardiovascular
    • Others
  • By End User
    • Hospitals
    • Specialty Clinics
    • Ambulatory Surgical Centers
    • Others
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Abbott Laboratories
    • Medtronic plc
    • Johnson & Johnson
    • Stryker Corporation
    • Zimmer Biomet Holdings, Inc.
    • Smith & Nephew plc
    • Boston Scientific Corporation
    • Biotronik SE & Co. KG
    • Terumo Corporation
    • Amaranth Medical, Inc.
    • Arthrex, Inc.
    • Bioretec Ltd.
    • REVA Medical, LLC
    • Tepha, Inc.
    • Corbion N.V.
    • DSM Biomedical
    • WL Gore & Associates, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Material Type
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Bioresorbable Implants Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Bioresorbable Implants Market, By Material Type, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Metallic
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Polymer
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Bioresorbable Implants Market, By Application, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Orthopedic
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Cardiovascular
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Bioresorbable Implants Market, By End User, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Hospitals
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Specialty Clinics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ambulatory Surgical Centers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Bioresorbable Implants Market, By Region, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • Abbott Laboratories
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Medtronic plc
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Johnson & Johnson
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Stryker Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Zimmer Biomet Holdings, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Smith & Nephew plc
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Boston Scientific Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Biotronik SE & Co. KG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Terumo Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Amaranth Medical, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Arthrex, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Bioretec Ltd.
    • REVA Medical, LLC
    • Tepha, Inc.
    • Corbion N.V.
    • DSM Biomedical
    • WL Gore & Associates, Inc.

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact